Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
_256_384.jpg)
It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.
At present 18 per cent of the local pharmaceutical market is under government's price control
The lab has been developed to aid surgeons to overcome the challenging learning curve to obtain laparoscopic expertise
This deal makes Meddo, one of the largest health-tech players in India
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
Subscribe To Our Newsletter & Stay Updated
